206 related articles for article (PubMed ID: 22738343)
21. Expression of the proliferation marker Ki-67 associates with tumour staging and clinical outcome in differentiated thyroid carcinomas.
Müssig K; Wehrmann T; Dittmann H; Wehrmann M; Ueberberg B; Schulz S; Bares R; Petersenn S
Clin Endocrinol (Oxf); 2012 Jul; 77(1):139-45. PubMed ID: 22248072
[TBL] [Abstract][Full Text] [Related]
22. In situ evidence of neoplastic cell phagocytosis by macrophages in papillary thyroid cancer.
Fiumara A; Belfiore A; Russo G; Salomone E; Santonocito GM; Ippolito O; Vigneri R; Gangemi P
J Clin Endocrinol Metab; 1997 May; 82(5):1615-20. PubMed ID: 9141559
[TBL] [Abstract][Full Text] [Related]
23. An evaluation of the clinical significance of FOXP3+ infiltrating cells in human breast cancer.
Mahmoud SM; Paish EC; Powe DG; Macmillan RD; Lee AH; Ellis IO; Green AR
Breast Cancer Res Treat; 2011 May; 127(1):99-108. PubMed ID: 20556505
[TBL] [Abstract][Full Text] [Related]
24. Chronic lymphocytic thyroiditis (CLT) has a positive prognostic value in papillary thyroid cancer (PTC) patients: the potential key role of Foxp3+ T lymphocytes.
Pilli T; Toti P; Occhini R; Castagna MG; Cantara S; Caselli M; Cardinale S; Barbagli L; Pacini F
J Endocrinol Invest; 2018 Jun; 41(6):703-709. PubMed ID: 29230715
[TBL] [Abstract][Full Text] [Related]
25. Foxp3 expression is associated with aggressiveness in differentiated thyroid carcinomas.
Cunha LL; Morari EC; Nonogaki S; Soares FA; Vassallo J; Ward LS
Clinics (Sao Paulo); 2012; 67(5):483-8. PubMed ID: 22666793
[TBL] [Abstract][Full Text] [Related]
26. Inflammatory cell infiltration of tumors: Jekyll or Hyde.
Talmadge JE; Donkor M; Scholar E
Cancer Metastasis Rev; 2007 Dec; 26(3-4):373-400. PubMed ID: 17717638
[TBL] [Abstract][Full Text] [Related]
27. Tumor infiltrating immune cells and outcome of Merkel cell carcinoma: a population-based study.
Sihto H; Böhling T; Kavola H; Koljonen V; Salmi M; Jalkanen S; Joensuu H
Clin Cancer Res; 2012 May; 18(10):2872-81. PubMed ID: 22467679
[TBL] [Abstract][Full Text] [Related]
28. Long-term outcome of patients with insular carcinoma of the thyroid: the insular histotype is an independent predictor of poor prognosis.
Pellegriti G; Giuffrida D; Scollo C; Vigneri R; Regalbuto C; Squatrito S; Belfiore A
Cancer; 2002 Nov; 95(10):2076-85. PubMed ID: 12412160
[TBL] [Abstract][Full Text] [Related]
29. Decreased staging of differentiated thyroid cancer in patients with chronic lymphocytic thyroiditis.
Borowczyk M; Janicki A; Dworacki G; Szczepanek-Parulska E; Danieluk M; Barnett J; Antonik M; Kałużna M; Bromińska B; Czepczyński R; Bączyk M; Ziemnicka K; Ruchała M
J Endocrinol Invest; 2019 Jan; 42(1):45-52. PubMed ID: 29619749
[TBL] [Abstract][Full Text] [Related]
30. Prognostic effect of epithelial and stromal lymphocyte infiltration in non-small cell lung cancer.
Al-Shibli KI; Donnem T; Al-Saad S; Persson M; Bremnes RM; Busund LT
Clin Cancer Res; 2008 Aug; 14(16):5220-7. PubMed ID: 18698040
[TBL] [Abstract][Full Text] [Related]
31. The role of the in situ local inflammatory response in predicting recurrence and survival in patients with primary operable colorectal cancer.
Roxburgh CS; McMillan DC
Cancer Treat Rev; 2012 Aug; 38(5):451-66. PubMed ID: 21945823
[TBL] [Abstract][Full Text] [Related]
32. Immunohistochemical patterns of reactive microenvironment are associated with clinicobiologic behavior in follicular lymphoma patients.
Alvaro T; Lejeune M; Salvadó MT; Lopez C; Jaén J; Bosch R; Pons LE
J Clin Oncol; 2006 Dec; 24(34):5350-7. PubMed ID: 17135637
[TBL] [Abstract][Full Text] [Related]
33. Pathologic complete response to neoadjuvant chemotherapy of breast carcinoma is associated with the disappearance of tumor-infiltrating foxp3+ regulatory T cells.
Ladoire S; Arnould L; Apetoh L; Coudert B; Martin F; Chauffert B; Fumoleau P; Ghiringhelli F
Clin Cancer Res; 2008 Apr; 14(8):2413-20. PubMed ID: 18413832
[TBL] [Abstract][Full Text] [Related]
34. The role of the inflammatory microenvironment in thyroid carcinogenesis.
Cunha LL; Marcello MA; Ward LS
Endocr Relat Cancer; 2014 Jun; 21(3):R85-R103. PubMed ID: 24302667
[TBL] [Abstract][Full Text] [Related]
35. Mammary tumor heterogeneity in the expansion of myeloid-derived suppressor cells.
Donkor MK; Lahue E; Hoke TA; Shafer LR; Coskun U; Solheim JC; Gulen D; Bishay J; Talmadge JE
Int Immunopharmacol; 2009 Jul; 9(7-8):937-48. PubMed ID: 19362167
[TBL] [Abstract][Full Text] [Related]
36. Immune cell infiltration of primary and metastatic lesions: mechanisms and clinical impact.
Talmadge JE
Semin Cancer Biol; 2011 Apr; 21(2):131-8. PubMed ID: 21145968
[TBL] [Abstract][Full Text] [Related]
37. Tumor-infiltrating cytotoxic T cells but not regulatory T cells predict outcome in anal squamous cell carcinoma.
Grabenbauer GG; Lahmer G; Distel L; Niedobitek G
Clin Cancer Res; 2006 Jun; 12(11 Pt 1):3355-60. PubMed ID: 16740757
[TBL] [Abstract][Full Text] [Related]
38. Prognostic significance of CD8+ T cell and macrophage peritumoral infiltration in colorectal cancer.
Funada Y; Noguchi T; Kikuchi R; Takeno S; Uchida Y; Gabbert HE
Oncol Rep; 2003; 10(2):309-13. PubMed ID: 12579264
[TBL] [Abstract][Full Text] [Related]
39. Hyaluronan expression in differentiated thyroid carcinoma.
Böhm J; Niskanen L; Tammi R; Tammi M; Eskelinen M; Pirinen R; Hollmen S; Alhava E; Kosma VM
J Pathol; 2002 Feb; 196(2):180-5. PubMed ID: 11793369
[TBL] [Abstract][Full Text] [Related]
40. Tumor-infiltrating CD14-positive myeloid cells and CD8-positive T-cells prolong survival in patients with cervical carcinoma.
de Vos van Steenwijk PJ; Ramwadhdoebe TH; Goedemans R; Doorduijn EM; van Ham JJ; Gorter A; van Hall T; Kuijjer ML; van Poelgeest MI; van der Burg SH; Jordanova ES
Int J Cancer; 2013 Dec; 133(12):2884-94. PubMed ID: 23740735
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
